Last reviewed · How we verify
NCT03906903: rTMS&MCI
Transcranial Magnetic Stimulation and Cognitive Stimulation in Mild Cognitive Impairment
NA trial testing Repetitive Transcranial Magnetic Stimulation in Mild Cognitive Impairment in 20 participants. Status unknown.
30 March 2019
Quick facts
| Lead sponsor | Universidad Autonoma de Queretaro |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 5 March 2018 |
| Primary completion | 30 March 2019 |
| Estimated completion | 30 August 2019 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Repetitive Transcranial Magnetic Stimulation
- Cognitive Stimulation
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
Sponsor
Universidad Autonoma de Queretaro
Who can join
Adults 60 to 85, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effect of 5Hertz (Hz) repetitive Transcranial Magnetic Stimulation (rTMS) on Left Dorsolateral Prefrontal Cortex enhancing Cognitive Stimulation in Mild Cognitive Impairment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03906903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Repetitive Transcranial Magnetic Stimulation
Trials testing the same drug.
- NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting
- NCT07211490 — rTMS for Cerebellar Ataxia in Children · NA · not yet recruiting
- NCT05139862 — Neurocardiac Predictors of Treatment Response to RTMS in Depression · NA · not yet recruiting
- NCT05883774 — Effects of rTMS on the Anxiety State of Older Patients With GAD · NA · not yet recruiting
- NCT06490965 — Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets · NA · recruiting
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other Universidad Autonoma de Queretaro trials
Trials by the same sponsor.
- NCT06817070 — Diet, Exercise, and Nutrition Challenges in Mexican Adults During COVID-19: A Study · completed
- NCT03832777 — Transcranial Magnetic Stimulation on Dorsomedial Prefrontal Cortex in Borderline Personality Disorder · NA · unknown
- NCT03540641 — Transcranial Magnetic Stimulation (TMS) in Binge Eating Disorder (BED) · NA · completed
- NCT05288101 — Effect of Oral Nutritional Supplementation Combined With Impedance Vectors · NA · completed
- NCT03571412 — Antidepressive Effect on 5 Herz (Hz) rTMS Over Dorsomedial Prefrontal Cortex and Left Dorsolateral Prefrontal Cortex · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03906903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Autonoma de Queretaro
- Last refreshed: 16 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03906903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing